🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase I/II trial studies the side effects and best dose of inotuzumab ...
Status
Recruiting
Location
M D Anderson Cancer Center
Start Date
2011-08-26
Trial ID
NCT01371630
To learn if cyclophosphamide, vincristine, and dexamethasone (called mini h...
Status
Recruiting
Location
M D Anderson Cancer Center
Start Date
2023-07-14
Trial ID
NCT05645718
This protocol is designed to assess the efficacy and safety of inotuzumab o...
Status
Terminated
Location
Facey Medical Group
Start Date
2007-11
Trial ID
NCT00562965
This is a phase 1 trial designed to evaluate safety and tolerability of che...
Status
Completed
Location
Davis Cancer Pavillion and Shands Medical Plaza
Start Date
2010-03
Trial ID
NCT01055496
This phase II trial studies how well combination chemotherapy and inotuzuma...
Status
Terminated
Location
M D Anderson Cancer Center
Start Date
2018-03-28
Trial ID
NCT03488225
This phase II trial compares the combination of inotuzumab ozogamicin and l...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2023-06-09
Trial ID
NCT05303792
This phase II trial studies how well blinatumomab, inotuzumab ozogamicin, a...
Status
Recruiting
Location
M D Anderson Cancer Center
Start Date
2016-11-01
Trial ID
NCT02877303